Six new products aimed at improving the quality of healthcare will take center stage at an event in June for life science innovators and investors reshaping the industry.
The Big Company/Little Company Showcase on Thursday, June 16, from 9 a.m. to 1:30 p.m., will be a free online program highlighting new medical devices and technologies. It will connect entrepreneurs, researchers and venture capitalists with each other and resources to advance their work.
The event is presented by the UMass Center for Advancing Point of Care Technologies (CAPCaT), a National Institutes of Health-funded business incubator that promotes innovations designed to improve the well-being of patients with heart, blood , lungs and sleep. The center is housed in the Massachusetts Medical Development Center (M2D2), a joint venture between UMass Lowell and Worcester-based UMass Chan Medical School. M2D2 assists entrepreneurs in all aspects of bringing new products and technologies from the drawing board to the market.
Among those welcoming session participants will be UMass Lowell Chancellor-elect Julie Chen.
This event highlights M2D2’s commitment to working with life science entrepreneurs, corporate partners and investors to advance innovations that improve health outcomes. UMass Lowell is proud to partner with our colleagues at UMass Chan Medical School to provide the expertise and resources needed to help medical device and biotechnology entrepreneurs realize their vision and develop viable commercial products. »
Julie Chen, chancellor-elect of UMass Lowell
Entrepreneurs from six startups developing point-of-service innovations will present their inventions to a panel of experts. Products featured include mobile apps that monitor lung and airway health as well as devices that assess iron levels in pediatric patients, monitor blood pressure, regulate oxygen delivery to patients receiving therapy emergency and provide hearing protection to infants in neonatal intensive care units.
“The CAPCaT collaboration between UMass Chan Medical School and UMass Lowell is one of the most innovative and rewarding I have been involved in,” said CAPCaT co-director Dr. David McManus, Professor Richard M. Haidack and chairman of the Department of Medicine at UMass Chan Medical School, where he is the founding director of the digital medicine program. “We look forward to another great big business/small business event exploring cutting-edge solutions to improve patient health.”
Girardin Jean-Louis, professor of psychiatry and neurology at the University of Miami and director of the Center on Translational Sleep and Circadian Sciences and the NIH-funded PRIDE Institute on Behavioral Medicine and Sleep Disorders, will deliver the session’s keynote address. .
“We are very pleased to welcome Dr. Jean-Louis, one of the world’s leading experts in advancing the science and practice of sleep science and circadian rhythms. His research focuses on the barriers to multiple levels that prevent adoption of healthy practices in underserved communities,” said Bryan Buchholz, co-director of CAPCaT and UMass Lowell professor and chair of the department of biomedical engineering.
Mara Aspinall, Managing Director of Healthcare Investments and Policy at BlueStone Venture Partners, and Kadir Kadhiresan, Vice President of Venture Capital Investments at Johnson & Johnson Innovation, will also host an interactive discussion on the medical device industry and biotechnology.
M2D2 has screened over 250 medical device and biotechnology companies and supported over 100 startups since its inception in 2007. In total, M2D2 resident companies have secured over $150 million in external funding for their innovations.